← Leaderboards

Sangeeta N. Bhatia

Boston University (Charles River Campus)

Google Scholar ↗PubMed ↗ORCID ↗

$17,612,668

Attributed

$27,000,102

Total exposure

10

Grants

5

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.1M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$27,000,102 · 10

By mechanism

R01$25,362,112 · 7

P42$1,043,911 · 1

R21$399,367 · 1

U54$194,712 · 1

Top collaborators

Most similar at Boston University (Charles River Campus)

Same institution · by research overlap

Ahmad Samir Khalil$14,060,977

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoTissuesIn VitroEngineeringLiverResearch PersonnelHepatocytePlayCellsTissue EngineeringSurfaceTechnologyPatternPhysiologicalCell CommunicationPharmaceutical PreparationsSiteComplexBaseLaboratoriesParacrine CommunicationSignal TransductionLiver FunctionLead

Grant awards (49)

Synthetic vascularization and regeneration in engineered tissues$535,365

R01 · FY2025 · EB

Synthetic vascularization and regeneration in engineered tissues$531,435

R01 · FY2024 · EB

Synthetic vascularization and regeneration in engineered tissues$565,247

R01 · FY2023 · EB

Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$784,101

R01 · FY2021 · AI

Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$788,842

R01 · FY2020 · AI

Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$800,521

R01 · FY2019 · AI

Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$805,479

R01 · FY2018 · AI

Engineering Multicellular Tissue Structure, Function, and Vascularization$759,128

R01 · FY2018 · EB

Infection-homing nanosystems as antibacterial therapeutics-delivery platforms$836,708

R01 · FY2017 · AI

Engineering Multicellular Tissue Structure, Function, and Vascularization$742,637

R01 · FY2017 · EB

Engineering Multicellular Tissue Structure, Function, and Vascularization$749,421

R01 · FY2016 · EB

Engineering Multicellular Tissue Structure, Function, and Vascularization$788,491

R01 · FY2015 · EB

Modeling human hepatotropic infections in complex tissue organoids$1,086,207

R01 · FY2013 · DK

Modeling human hepatotropic infections in complex tissue organoids$1,110,614

R01 · FY2012 · DK

Engineering Multicellular Tissue Structure, Function and Vascularization$663,186

R01 · FY2012 · EB

Modeling human hepatotropic infections in complex tissue organoids$1,101,742

R01 · FY2011 · DK

Engineering Multicellular Tissue Structure, Function and Vascularization$673,147

R01 · FY2011 · EB

Role of Tissue Micro-Architecture on Hepatocyte Function$328,114

R01 · FY2011 · DK · contact PI

Modeling human hepatotropic infections in complex tissue organoids$1,126,288

R01 · FY2010 · DK

Engineering Multifunctional Nanoparticles$797,711

R01 · FY2010 · CA · contact PI

Engineering Multicellular Tissue Structure, Function and Vascularization$700,285

R01 · FY2010 · EB

Role of Tissue Micro-Architecture on Hepatocyte Function$341,881

R01 · FY2010 · DK · contact PI

Modeling human hepatotropic infections in complex tissue organoids$1,135,336

R01 · FY2009 · DK

Engineering Multifunctional Nanoparticles$811,057

R01 · FY2009 · CA · contact PI

Engineering Multicellular Tissue Structure, Function and Vascularization$733,070

R01 · FY2009 · EB

Engineering Multifunctional Nanoparticles$569,049

R01 · FY2009 · CA · contact PI

Role of Tissue Micro-Architecture on Hepatocyte Function$345,842

R01 · FY2009 · DK · contact PI

Microscale Engineered Liver Tissue for Toxicant Testing$212,875

P42 · FY2009 · ES · contact PI

Experimental and theoretical multiscale model of sickle cell vaso-occlusion in a$167,417

R21 · FY2009 · HL

TOXICITY CORE$116,310

U54 · FY2009 · CA · contact PI

Engineering Multifunctional Nanoparticles$817,618

R01 · FY2008 · CA · contact PI

Role of Tissue Micro-Architecture on Hepatocyte Function$342,972

R01 · FY2008 · DK · contact PI

Experimental and theoretical multiscale model of sickle cell vaso-occlusion in a$231,950

R21 · FY2008 · HL

Microscale Engineered Liver Tissue for Toxicant Testing$216,137

P42 · FY2008 · ES · contact PI

TOXICITY CORE$78,402

U54 · FY2008 · CA · contact PI

Engineering Multifunctional Nanoparticles$837,291

R01 · FY2007 · CA · contact PI

Role of Tissue Micro-Architecture on Hepatocyte Function$366,697

R01 · FY2007 · DK · contact PI

Microscale Engineered Liver Tissue for Toxicant Testing$211,490

P42 · FY2007 · ES · contact PI

Engineering Multifunctional Nanoparticles$892,000

R01 · FY2006 · CA · contact PI

Intercellular Communications in Hepatic Function$289,437

R01 · FY2006 · DK · contact PI

Microscale Engineered Liver Tissue for Toxicant Testing$199,891

P42 · FY2006 · ES · contact PI

Intercellular Communications in Hepatic Function$296,731

R01 · FY2005 · DK

Microscale Engineered Liver Tissue for Toxicant Testing$203,518

P42 · FY2005 · ES

Intercellular Communications in Hepatic Function$282,727

R01 · FY2004 · DK

Intercellular Communications in Hepatic Function$351,483

R01 · FY2003 · DK

ROLE OF TISSUE MICRO ARCHITECTURE ON HEPATOCYTE FUNCTION$171,110

R01 · FY2003 · DK

ROLE OF TISSUE MICRO ARCHITECTURE ON HEPATOCYTE FUNCTION$166,125

R01 · FY2002 · DK

ROLE OF TISSUE MICRO ARCHITECTURE ON HEPATOCYTE FUNCTION$161,288

R01 · FY2001 · DK

ROLE OF TISSUE MICRO ARCHITECTURE ON HEPATOCYTE FUNCTION$175,729

R01 · FY2000 · DK